These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10172485)

  • 1. Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
    Oliva-Moreno J; Puig-Junoy J; Trapero-Bertran M; Epstein D; Pinyol C; Sacristán JA
    Value Health; 2020 Jan; 23(1):25-31. PubMed ID: 31952669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers?
    Teerawattananon Y; Russell S; Mugford M
    Pharmacoeconomics; 2007; 25(6):467-79. PubMed ID: 17523752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simulation model to evaluate pharmaceutical supply chain costs in hospitals: the case of a Colombian hospital.
    Franco C
    Daru; 2020 Jun; 28(1):1-12. PubMed ID: 30565158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study.
    Schreiber K; Kant M; Pfleger C; Jensen HB; Oesterberg O; Hald AR; Nielsen FK; Rubak S
    Patient Prefer Adherence; 2018; 12():1139-1150. PubMed ID: 29988735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
    van Velden ME; Severens JL; Novak A
    Pharmacoeconomics; 2005; 23(11):1075-82. PubMed ID: 16277545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.
    Tan HL
    Pharmacoeconomics; 2000 Jan; 17(1):77-107. PubMed ID: 10747767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.
    Glennie JL; Torrance GW; Baladi JF; Berka C; Hubbard E; Menon D; Otten N; Rivière M
    Pharmacoeconomics; 1999 May; 15(5):459-68. PubMed ID: 10537963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of health economic information by reimbursement authorities.
    Drummond MF
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii60-3. PubMed ID: 14585919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions.
    Roy S; Madhavan SS
    Pharmacoeconomics; 2008; 26(4):281-96. PubMed ID: 18370564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of drugs and its potential uses in policy making.
    Johannesson M
    Pharmacoeconomics; 1995 Sep; 8(3):190-8. PubMed ID: 10172485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.
    Hoomans T; Severens JL; van der Roer N; Delwel GO
    Pharmacoeconomics; 2012 Mar; 30(3):219-27. PubMed ID: 22074610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
    Delwel GO; Sprenger MJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.